Dr MeiLan Han, of the University of Michigan, Ann Arbor, highlights studies in chronic obstructive pulmonary disease (COPD) presented at the CHEST 2021 Annual Meeting. Dr Han first reports on a study ...
Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...
Eosinophil Granulocytes COPD Patients with COPD who exhibit low blood eosinophil counts had no change in exacerbations or survival compared with patients with typical counts. Patients with chronic ...
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the "exclusive" use of ...
Cases of COVID-19, particularly severe ones, may increase a person’s risk of developing a pulmonary embolism. COVID-19 is a highly contagious, rapidly spreading illness. It can cause pneumonia, cold, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback